{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:37:55Z","timestamp":1773513475612,"version":"3.50.1"},"reference-count":101,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Bronchiectasis is a heterogenous disease with multiple aetiologies resulting in inflammation and dilatation of the airways with associated mucus production and chronic respiratory infection. The condition is being recognised ever more frequently as the availability of computed tomography increases. It is associated with significant morbidity and healthcare-related costs. With new understanding of the disease process, varying endotypes, identification of underlying causes and treatable traits, the management of bronchiectasis can be increasingly personalised.<\/jats:p>","DOI":"10.3390\/jpm13010133","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T01:30:47Z","timestamp":1673314247000},"page":"133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Insights into Personalised Medicine in Bronchiectasis"],"prefix":"10.3390","volume":"13","author":[{"given":"Clementine S.","family":"Fraser","sequence":"first","affiliation":[{"name":"Host Defence, Respiratory Medicine, Royal Brompton Hospital, 37 Fulham Road, Chelsea, London SW3 6NP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-6862","authenticated-orcid":false,"given":"Ricardo J.","family":"Jos\u00e9","sequence":"additional","affiliation":[{"name":"Host Defence, Respiratory Medicine, Royal Brompton Hospital, 37 Fulham Road, Chelsea, London SW3 6NP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: Results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet. Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.25259\/JPATS_5_2021","article-title":"Knowledge, attitudes, and practice about bronchiectasis among general practitioners in four African cities","volume":"2","author":"Ouedraogo","year":"2021","journal-title":"J. Pan Afr. Thorac. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: A first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Aliberti, S., Sotgiu, G., Lapi, F., Gramegna, A., Cricelli, C., and Blasi, F. (2020). Prevalence and incidence of bronchiectasis in Italy. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-1050-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Park, D.I., Kang, S., and Choi, S. (2021). Evaluating the prevalence and incidence of bronchiectasis and nontuberculous mycobacteria in south korea using the nationwide population data. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18179029"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1479972317702139","article-title":"Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish historical registry of bronchiectasis","volume":"14","author":"Olveira","year":"2017","journal-title":"Chron. Respir. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004728-198206000-00001","article-title":"Computed tomography of bronchiectasis","volume":"6","author":"Naidich","year":"1982","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1817-1737.82443","article-title":"Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis","volume":"6","author":"Habesoglu","year":"2011","journal-title":"Ann. Thorac. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1183\/20734735.0009-2019","article-title":"Diagnostic imaging in adult non-cystic fibrosis bronchiectasis","volume":"15","author":"Juliusson","year":"2019","journal-title":"Breathe"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","article-title":"Phenotyping adults with non-cystic fibrosis bronchiectasis: A prospective observational cohort study","volume":"107","author":"Anwar","year":"2013","journal-title":"Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population: Effects of ethnicity on etiology and sputum culture","volume":"142","author":"McShane","year":"2012","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, R., mac Aog\u00e1in, M., Chalmers, J.D., Elborn, S.J., and Chotirmall, S.H. (2018). Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm. Med., 18.","DOI":"10.1186\/s12890-018-0638-0"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.13068","article-title":"Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy","volume":"191","author":"Stubbs","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajhg.2016.11.019","article-title":"Mutations in PIH1D3 cause X-linked primary ciliary dyskinesia with outer and inner dynein arm defects","volume":"100","author":"Paff","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajhg.2019.09.022","article-title":"De novo mutations in FOXJ1 result in a motile ciliopathy with hydrocephalus and randomization of left\/right body asymmetry","volume":"105","author":"Wallmeier","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1726","DOI":"10.1002\/mgg3.1726","article-title":"Autosomal dominant variants in FOXJ1 causing primary ciliary dyskinesia in two patients with obstructive hydrocephalus","volume":"9","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/09031936.00001010","article-title":"Factors influencing age at diagnosis of primary ciliary dyskinesia in European children","volume":"36","author":"Kuehni","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/humu.22957","article-title":"Systematic analysis of CCNO variants in a defined population: Implications for clinical phenotype and differential diagnosis","volume":"37","author":"Amirav","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/thoraxjnl-2015-206938","article-title":"Characteristics of COPD in never-smokers and ever-smokers in the general population: Results from the CanCOLD study","volume":"70","author":"Tan","year":"2015","journal-title":"Thorax"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201208-1518OC","article-title":"Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease","volume":"187","author":"Carrillo","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","article-title":"Asthma and bronchiectasis exacerbation","volume":"47","author":"Mao","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/resp.13005","article-title":"Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics","volume":"22","author":"Venning","year":"2017","journal-title":"Respirology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","article-title":"Bronchiectasis: Current concepts in pathogenesis, immunology, and microbiology","volume":"11","author":"Boyton","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: The E-FACED score","volume":"12","author":"Athanazio","year":"2017","journal-title":"Int. J. COPD"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: The FACED score","volume":"43","author":"Relat","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874306401509010046","article-title":"Assessment of the non-cystic fibrosis bronchiectasis severity: The FACED score vs. the bronchiectasis severity index","volume":"9","author":"Minov","year":"2015","journal-title":"Open Respir. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2016-208481","article-title":"Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts","volume":"71","author":"McDonnell","year":"2016","journal-title":"Thorax"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12931-019-1243-3","article-title":"Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis","volume":"20","author":"Sin","year":"2019","journal-title":"Respir. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: A long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/13993003.01312-2015","article-title":"Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: A 19-year cohort study","volume":"47","author":"Ellis","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1513\/AnnalsATS.202111-1257OC","article-title":"Non-cystic fibrosis bronchiectasis increases the risk of lung cancer independent of smoking status","volume":"19","author":"Choi","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/JTO.0b013e3181f387e4","article-title":"The role of inflammation in the pathogenesis of non-small cell lung cancer","volume":"5","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201508-1545CI","article-title":"Macrophages, inflammation, and lung cancer","volume":"193","author":"Conway","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wang, H., Yang, L., Zou, L., Huang, N., Guo, Y., Pan, M., Tan, Y., Zhong, H., Ji, W., and Ran, P. (2012). Association between chronic obstructive pulmonary disease and lung cancer: A case-control study in southern chinese and a meta-analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046144"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40169-015-0068-z","article-title":"Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer","volume":"4","author":"King","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ho, L.-J., Yang, H.-Y., Chung, C.-H., Chang, W.-C., Yang, S.-S., Sun, C.-A., Chien, W.-C., and Su, R.-Y. (2021). Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250531"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hwang, S.Y., Kim, J.Y., Lee, H.S., Lee, S., Kim, D., Kim, S., Hyun, J.H., Shin, J.I., Lee, K.H., and Han, S.H. (2022). Pulmonary tuberculosis and risk of lung cancer: A systematic review and meta-analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030765"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.21037\/jtd.2020.01.38","article-title":"Effects of age on the association between pulmonary tuberculosis and lung cancer in a South Korean cohort","volume":"12","author":"An","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e014613","DOI":"10.1136\/bmjopen-2016-014613","article-title":"Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: A retrospective study","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Soriano","year":"2007","journal-title":"Chest"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rmed.2011.11.018","article-title":"Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis","volume":"106","author":"White","year":"2012","journal-title":"Respir. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"McDonnell","year":"2015","journal-title":"Respir. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2005.046631","article-title":"Non-tuberculous mycobacteria in patients with bronchiectasis","volume":"60","author":"Wickremasinghe","year":"2005","journal-title":"Thorax"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"M\u00e1iz, L., Gir\u00f3n, R., Olveira, C., Vendrell, M., Nieto, R., and Mart\u00ednez-Garc\u00eda, M.A. (2016). Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: A multicenter observational study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1774-x"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.06.00149805","article-title":"Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics","volume":"28","author":"Fowler","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kwak, N., Lee, J.H., Kim, H.-J., Kim, S.A., and Yim, J.-J. (2020). New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: Tracking the clinical and radiographic changes. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01331-3"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1183\/09031936.06.00139005","article-title":"Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis","volume":"28","author":"Kunst","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00140007","article-title":"Susceptibility to nontuberculous mycobacterial lung disease","volume":"31","author":"Sexton","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1378\/chest.101.6.1605","article-title":"Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern; The Lady Windermere syndrome","volume":"101","author":"Reich","year":"1992","journal-title":"Chest"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood neutrophils are reprogrammed in bronchiectasis","volume":"198","author":"Bedi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_55","first-page":"PA2170","article-title":"Inflammatory molecular endotypes in bronchiectasis","volume":"54","author":"Shoemark","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_56","first-page":"OA1311","article-title":"Mapping inflammatory endotypes of bronchiectasis associated with impaired mucociliary clearance","volume":"58","author":"Bottier","year":"2021","journal-title":"Conf. ERS Int. Congr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2003157","DOI":"10.1183\/13993003.03157-2020","article-title":"Neutrophil dysfunction in bronchiectasis: An emerging role for immunometabolism","volume":"58","author":"Giam","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_59","first-page":"27","article-title":"Validation of AMP-activated protein kinase as a therapeutic target in bronchiectasis","volume":"6","author":"Giam","year":"2020","journal-title":"ERJ Open Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"126644","DOI":"10.1016\/j.micres.2020.126644","article-title":"Avoiding the trap: Mechanisms developed by pathogens to escape neutrophil extracellular traps","volume":"243","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: An international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4103\/0366-6999.201608","article-title":"Role of neutrophil extracellular traps in asthma and chronic obstructive pulmonary disease","volume":"130","author":"Liu","year":"2017","journal-title":"Chin. Med. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaci.2017.04.022","article-title":"Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease","volume":"141","author":"Dicker","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis a european multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_66","first-page":"PA2665","article-title":"Peripheral blood eosinophilia and clinical phenotype in bronchiectasis","volume":"52","author":"Finch","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Oriano, M., Gramegna, A., Amati, F., D\u2019Adda, A., Gaffuri, M., Contoli, M., Bindo, F., Simonetta, E., Di Francesco, C., and Santambrogio, M. (2021). T2-high endotype and response to biological treatments in patients with bronchiectasis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070772"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","article-title":"The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis","volume":"99","author":"Tsikrika","year":"2017","journal-title":"Cytokine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-019-1042-x","article-title":"Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): A randomized controlled trial","volume":"20","author":"Qi","year":"2019","journal-title":"Respir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: A randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s40265-020-01412-x","article-title":"Multifaceted beneficial effects of erdosteine: More than a mucolytic agent","volume":"80","author":"Cazzola","year":"2020","journal-title":"Drugs"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis","volume":"326","author":"Hubbard","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"Management of bronchiectasis in adults","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_74","first-page":"CD001289","article-title":"Mucolytics for bronchiectasis","volume":"2014","author":"Wilkinson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/resp.13047","article-title":"Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis","volume":"22","author":"Tarrant","year":"2017","journal-title":"Respirology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase, I. rhDNase study group","volume":"113","author":"Barker","year":"1998","journal-title":"Chest"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1164\/ajrccm.154.2.8756815","article-title":"Short-term recombinant human DNase in bronchiectasis: Effect on clinical state and in vitro sputum transportability","volume":"154","author":"Wills","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.rmed.2005.12.002","article-title":"Inhaled steroids improve quality of life in patients with steady-state bronchiectasis","volume":"100","year":"2006","journal-title":"Respir Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thx.2002.003236","article-title":"Inhaled fluticasone in bronchiectasis: A 12 month study","volume":"60","author":"Tsang","year":"2005","journal-title":"Thorax"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2000453","DOI":"10.1183\/13993003.00453-2020","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"106127","DOI":"10.1016\/j.rmed.2020.106127","article-title":"Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials","volume":"172","author":"Posadas","year":"2020","journal-title":"Respir. Med."},{"key":"ref_82","first-page":"CD000996","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"2018","author":"Kapur","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/1817-1737.74273","article-title":"Surgery for bronchiectasis: The effect of morphological types to prognosis","volume":"6","author":"Cobanoglu","year":"2011","journal-title":"Ann. Thorac. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1010-7940(01)00746-1","article-title":"Surgery for bronchiectasis","volume":"20","author":"Prieto","year":"2001","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"New Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.anai.2020.11.014","article-title":"Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis","volume":"126","author":"Kudlaty","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.200603-370OC","article-title":"Mutations of DNAI1 in primary ciliary dyskinesia: Evidence of founder effect in a common mutation","volume":"174","author":"Zariwala","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Chhin, B., Negre, D., Merrot, O., Pham, J., Tourneur, Y., Ressnikoff, D., Jaspers, M., Jorissen, M., Cosset, F.-L., and Bouvagnet, P. (2009). Ciliary beating recovery in deficient human airway epithelial cells after lentivirus ex vivo gene therapy. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000422"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ba\u00f1uls, L., Pellicer, D., Castillo, S., Navarro-Garc\u00eda, M.M., Magall\u00f3n, M., Gonz\u00e1lez, C., and Das\u00ed, F. (2020). Gene therapy in rare respiratory diseases: What have we learned so far?. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082577"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2860","article-title":"Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model","volume":"18","author":"McIntyre","year":"2012","journal-title":"Nat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1165\/rcmb.2009-0118OC","article-title":"Conditional deletion of Dnaic1 in a murine model of primary ciliary dyskinesia causes chronic rhinosinusitis","volume":"43","author":"Ostrowski","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jmedgenet-2015-103539","article-title":"Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia","volume":"53","author":"Lai","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Paff, T., Omran, H., Nielsen, K.G., and Haarman, E.G. (2021). Current and future treatments in primary ciliary dyskinesia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189834"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2000455","DOI":"10.1183\/13993003.00455-2020","article-title":"Higher throughput drug screening for rare respiratory diseases: Readthrough therapy in primary ciliary dyskinesia","volume":"58","author":"Lee","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: A review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41598-018-37636-x","article-title":"Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model","volume":"9","author":"Cafora","year":"2019","journal-title":"Sci Rep."},{"key":"ref_101","unstructured":"(2015). Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients with Chronic Pseudomonas Aeruginosa Pulmonary Infection. Drug Des. Dev. Ther., 9, 3653\u20133663. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05010577."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/1\/133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:05:06Z","timestamp":1760119506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/1\/133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jpm13010133"],"URL":"https:\/\/doi.org\/10.3390\/jpm13010133","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}